Dr. Astrid Schroeder has over 20 years of experience in clinical diagnostics. She began her career at Qiagen in Germany. Over the course of her career, she has worked at Nanogen, Gen-Probe/Hologic, GenMark Diagnostics, and ChromaCode. She has served as a CSLI committee member and helped author guidance documents for the development of IVD assays. Astrid joined Truvian Health as Sr. Director in Assay Development in 2021.
Dr. Schroeder received her M.S. and Ph.D. in Biophysics and Virology from Heinrich-Heine-University in Duesseldorf (Germany) and completed her post-doctoral training in Virology at the Salk Institute for Biological Studies in La Jolla in 2002.